Evaluation of the relationship between vitamin D3 and hemoglobin in patients undergoing hemodialysis

Phase 2

• Conditions: Anemia in chronic kidney disease.; Anemia in chronic kidney disease; D63.1

• Registration Number: IRCT20190202042588N2
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Age over 18 years
Patients undergoing dialysis more than or equal to 3 times a week for more than or equal to 90 days
Receive standard treatment for anemia (erythropoietin and Venofer ampoules) for at least three months
Life expectancy of more than 6 months
Absence of gastrointestinal disease or surgery that affects the absorption of vitamin D.
Intact Parathyroid Hormone(IPTH)= 150-350pg/ml

Exclusion Criteria

Hemoglobinopathy
Chronic liver disease
Dissatisfaction of patient companions
Patients who do not return one month later
pregnancy
Dialysis adequacy is less than 1.4 in the last three months
Transfusion over the past three months
Hypercalcemia over the past month (> 10)
Hyperphosphatemia over the past month (> 5)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hemoglobin level. Timepoint: One and three months after the start of the trial. Method of measurement: Complete Blood Count.